MicroRNA-based therapy and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment
MicroRNAs (miRNA) are 21–23 nucleotide molecules not translated into proteins that bind and target the 3′ untranslated regions of mRNA. These characteristics make them a possible tool for inhibiting protein translation. Different cellular pathways involved in cancer development, such as cellular pro...
Main Authors: | Rahmat, Asmah, Ling, King Hwa, Ismail, Patimah, Kaboli, Parham Jabbarzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Academic Press
2015
|
Online Access: | http://psasir.upm.edu.my/id/eprint/45473/1/DRUG.pdf |
Similar Items
-
Targets and mechanisms of berberine,a natural drug with potential to treat cancer with special focus on breast cancer
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2014) -
Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021) -
Molecular modelling of berberine derivatives as inhibitors of oncogenic signalling pathways in breast cancer cell lines
by: Kaboli, Parham Jabbarzadeh
Published: (2017) -
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
by: Tomoko Tadokoro, et al.
Published: (2021-07-01) -
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
by: Alexis Forterre, et al.
Published: (2020-07-01)